Goodwill and Other Intangible Assets

12 Months Ended

Feb. 01, 2014

Goodwill and Intangible Assets Disclosure [Abstract]

At February 1, 2014 and February 2, 2013, the Company reported goodwill of $200.6 million, net of accumulated impairment charges of $111.3 million. There was no change in the carrying value of goodwill during fiscal 2013 or fiscal 2012. No impairment charges were recorded for goodwill in fiscal 2013, 2012 or 2011.

The Company had indefinite-lived and finite-lived intangible assets of $89.5 million and $8.8 million, respectively, as of February 1, 2014 and $89.3 million and $9.6 million, respectively, as of February 2, 2013. No impairment charges were recorded for the Company's intangible assets in fiscal 2013, 2012 or 2011.

The components of intangible assets were as follows (in thousands):



	2013					2012
	Gross Amount		Accumulated Amortization			Gross Amount		Accumulated Amortization
Trademarks (indefinite-lived)	$	68,730	$	—		$	68,730	$	—
Trade name (indefinite-lived)	15,900		—			15,900		—
Customer list	1,200		(1,200		)	1,200		(960		)
Favorable leases and other finite-lived intangible assets	16,454		(7,674		)	14,954		(5,580		)
Other indefinite-lived intangible assets	4,845		—			4,659		—
Total intangible assets	$	107,129	$	(8,874	)	$	105,443	$	(6,540	)

Amortization expense for the Company's finite-lived intangible assets was $2.3 million, $2.0 million and $1.4 million for fiscal 2013, 2012 and 2011, respectively. The annual estimated amortization expense of the finite-lived intangible assets recorded as of February 1, 2014 is expected to be as follows (in thousands):



Fiscal Year	Estimated Amortization Expense
2014	$	1,767
2015	1,692
2016	1,546
2017	1,351
2018	1,114
Thereafter	1,310
Total	$	8,780

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details